Fertility-sparing surgery for patients with malignant ovarian germ cell tumors: 10 years of clinical experience from a tertiary referral center

Autor: Mislav Mikuš, Velena Radošević, Mario Ćorić, Pavao Planinić, Goran Vujić, Nikolina Benco, Tomislav Puževski, Helena Lovrić, Luka Matak, Mirna Bajt
Jazyk: angličtina
Rok vydání: 2020
Předmět:
medicine.medical_treatment
Tertiary Care Centers
0302 clinical medicine
Obstetrics and gynaecology
Pregnancy
Laparotomy
Medicine
Laparoscopy
Ovarian Neoplasms / drug therapy
Ovarian Neoplasms
030219 obstetrics & reproductive medicine
medicine.diagnostic_test
Teratoma
Obstetrics and Gynecology
Teratoma / pathology
Fertility Preservation
Neoplasms
Germ Cell and Embryonal / pathology

General Medicine
Middle Aged
Neoplasms
Germ Cell and Embryonal

Neoplasms
Germ Cell and Embryonal / drug therapy

Omentum / surgery
Chemotherapy
Adjuvant

030220 oncology & carcinogenesis
Ovarian Neoplasms / surgery
Female
medicine.symptom
Chemotherapy
Adjuvant / adverse effects

Adjuvant chemotherapy
Fertility-sparing surgery
Malignant ovarian germ cell tumors
Reproductive outcome
Omentum
Ovariectomy / methods
Adult
medicine.medical_specialty
Adolescent
Croatia
Ovariectomy
Ovarian Neoplasms / pathology
03 medical and health sciences
Young Adult
Humans
Neoplasm Staging
Retrospective Studies
Chemotherapy
business.industry
Neoplasm Recurrence
Local / pathology

Abdominal distension
medicine.disease
Surgery
Fertility
Neoplasms
Germ Cell and Embryonal / surgery

Lymph Node Excision
Immature teratoma
Lymphadenectomy
Germ cell tumors
Neoplasm Recurrence
Local

business
Popis: Purpose: To describe a case series of patients with malignant ovarian germ cell tumors (MOGCT) treated exclusively with fertility-sparing surgery (FSS) with or without adjuvant chemotherapy. ----- Methods: We retrospectively reviewed the records of 27 patients with MOGCT treated in the Department of Obstetrics and Gynecology, University Hospital Center Zagreb, Croatia, between January 2009 and July 2019. ----- Results: The median age at diagnosis was 22 years, and the main symptom was abdominal distension (57.0%). The most prevalent histological subtype was immature teratoma (n = 13, 48.1%). Twenty-three patients (85.2%) had laparotomy and 4 (14.8%) had laparoscopy, without conversions. Lymphadenectomy was performed in 16 (59.3%) patients, with 184 removed lymph nodes, and omentectomy was performed in 19 (70.4%) patients. The rate of chemotherapy administration was 81.5%. The follow-up length ranged between 6.30 and 115.1 months (median: 49.60 months). No patient experienced tumor recurrence. The rate of complete gross resection was 100%. At the time of analysis, all patients were alive and disease free. Fifty percent of patients who actively tried to conceive after FSS became pregnant, with 12 deliveries. ----- Conclusion: This study suggests that FSS is a safe treatment option for MOGCT, regardless of tumor stage and histological type.
Databáze: OpenAIRE